Otological therapy induces imunnotoxicity in dog

Abstract

Pharmacodermia can be defined as adverse reactions in skin, mucous membranes and appendages, sometimes having immunomediated character. The diagnosis is based on the patient clinical-laboratorial evaluation, involving a research about factors related to the drug use and its adverse effects. In veterinary medicine, reports of pharmacodermic reactions are scarce. Therefore, the aim of the present study is to report an adverse reaction after otologic therapy in dogs. A 2-year-old female canine patient with a history of bilateral auricular pruritus with a three-week course was attended. At the time, auricular cytology was performed, evidencing the presence of high numbers of yeast cells and cocci, as well as desquamative cells. It was then opted for otologic solution composed of Gentamicin, Clotrimazole, Betamethasone and Benzocaine. The clinical presentation progressed satisfactorily until the tenth day of treatment, when the patient presented intense erythema and meliceric secretion. Cytological examination was repeated, as well as culture of aerobic bacteria. A piogranulomatous inflammatory infiltrate with low bacterial and fungal content was evidenced in these examinations, corroborating with the findings of the bacterial culture. Faced with the suspicion of pharmacodermia, all therapeutic compounds were exchanged, and the patient progressed satisfactorily until the end of the treatment. Because it is still a composed otological solution, the cause of the reaction can not be attributed to specifically one of the compounds. However, there is a need to raise the awareness of the veterinarian about the identification and appropriate intervention in adverse drug reactions, as well as his scientific contribution to the dissemination of this information.